227 related articles for article (PubMed ID: 35172803)
1. Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker.
Niu H; Chen P; Fan L; Sun B
BMC Med Genomics; 2022 Feb; 15(1):29. PubMed ID: 35172803
[TBL] [Abstract][Full Text] [Related]
2. Diverse CBX family members as potential prognostic biomarkers in non-small-cell lung cancer.
Xie X; Ning Y; Long J; Wang H; Chen X
FEBS Open Bio; 2020 Oct; 10(10):2206-2215. PubMed ID: 32894652
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Pan-Cancer Revealed the Immunological and Prognostic Potential of CBX3 in Human Tumors.
Xu H; Jiang C; Chen D; Wu Y; Lu J; Zhong L; Yao F
Front Med (Lausanne); 2022; 9():869994. PubMed ID: 35573019
[TBL] [Abstract][Full Text] [Related]
4. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Pan-Cancer Analysis of GINS2 for Human Tumour Prognosis and as an Immunological Biomarker.
Meng W; Jiang Z; Zhang X; Cai B; Ma L; Guan Y
Comput Math Methods Med; 2022; 2022():3119721. PubMed ID: 36466552
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and Prognostic Significance of CBX3 Expression in Human Cancer: a Systematic Review and Meta-analysis.
Lin H; Zhao X; Xia L; Lian J; You J
Dis Markers; 2020; 2020():2412741. PubMed ID: 33273987
[TBL] [Abstract][Full Text] [Related]
7. CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma.
Zhong X; Kan A; Zhang W; Zhou J; Zhang H; Chen J; Tang S
Aging (Albany NY); 2019 Aug; 11(15):5483-5497. PubMed ID: 31375643
[TBL] [Abstract][Full Text] [Related]
8. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
Front Immunol; 2021; 12():781087. PubMed ID: 35069553
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of CBX3 in Pancreatic Adenocarcinoma Promotes Cell Cycle Transition-Associated Tumor Progression.
Chen LY; Cheng CS; Qu C; Wang P; Chen H; Meng ZQ; Chen Z
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29903985
[TBL] [Abstract][Full Text] [Related]
11. CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
Ma C; Nie XG; Wang YL; Liu XH; Liang X; Zhou QL; Wu DP
Mol Med Rep; 2019 May; 19(5):4205-4212. PubMed ID: 30942427
[TBL] [Abstract][Full Text] [Related]
12. CBX3 is a Prognostic Biomarker Correlated with ATR Activation and Immune Infiltration in Head and Neck Squamous Cell Carcinoma.
Zhang X; Zhou W; Zhang Y; Liu Z
Int J Gen Med; 2022; 15():1497-1508. PubMed ID: 35210823
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis.
Liu P; Wang X; Pan L; Han B; He Z
Front Immunol; 2022; 13():901784. PubMed ID: 35720327
[TBL] [Abstract][Full Text] [Related]
14. CBX3 promotes tumor proliferation by regulating G1/S phase via p21 downregulation and associates with poor prognosis in tongue squamous cell carcinoma.
Zhang H; Chen W; Fu X; Su X; Yang A
Gene; 2018 May; 654():49-56. PubMed ID: 29462646
[TBL] [Abstract][Full Text] [Related]
15. Members of the Chromobox Family Have Prognostic Value in Hepatocellular Carcinoma.
Pan C; Luo N; Guo K; Wang W; Li L; Fan N; Tian Y
Front Genet; 2022; 13():887925. PubMed ID: 35677563
[TBL] [Abstract][Full Text] [Related]
16. HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer.
Yang Z; Xu D; Ye X; Lin X; Zhang M; Su Y; Xie Q; Ni W
Biomed Res Int; 2022; 2022():3924400. PubMed ID: 35252444
[TBL] [Abstract][Full Text] [Related]
17. Targeting
Le PT; Ha N; Tran NK; Newman AG; Esselen KM; Dalrymple JL; Schmelz EM; Bhandoola A; Xue HH; Singh PB; Thai TH
Front Immunol; 2021; 12():738958. PubMed ID: 34721405
[TBL] [Abstract][Full Text] [Related]
18. SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer.
Liu X; Yuan R; Peng J; Xu A; Nie X; Tang R; Li G
Sci Rep; 2024 Jan; 14(1):1070. PubMed ID: 38212657
[TBL] [Abstract][Full Text] [Related]
19. GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer.
Chen G; Luo D; Zhong N; Li D; Zheng J; Liao H; Li Z; Lin X; Chen Q; Zhang C; Lu Y; Chan YT; Ren Q; Wang N; Feng Y
Front Immunol; 2022; 13():857308. PubMed ID: 35345673
[TBL] [Abstract][Full Text] [Related]
20. CBX3 Promotes Gastric Cancer Progression and Affects Factors Related to Immunotherapeutic Responses.
Lin H; Lian J; Xia L; Guan G; You J
Cancer Manag Res; 2020; 12():10113-10125. PubMed ID: 33116867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
